PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26967696 ↗2016Reported benefit

(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.

RatOtherSprague-DawleyMaleIntrathecal via indwelling PE-10 catheter3 micrograms in 5 microlitres intrathecally (stated for the…After injury: 24 h after paw incision, 7 to 9 days after spared nerve injury, 7…

Model: Plantar incision model of postoperative pain, spared nerve injury and L5/L6 spinal nerve ligation

A single intrathecal dose of (S)-lacosamide reversed mechanical allodynia and thermal hyperalgesia in the postoperative incision model and reversed allodynia in both neuropathic models, with onset around 30 min post-surgically and around 2 h in neuropathic pain and roughly 4 h duration. No sedation…

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.